SCHEMBL483306

SCHEMBL483306

C=CNC(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 1/20 0.56
CA12 O43570 2/20 0.55
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA9 Q16790 2/20 0.55
ALDH1A1 P00352 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NPC1 O15118 2/20 0.55
POLB P06746 2/20 0.55
RAB9A P51151 2/20 0.55
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
MAPT P10636 1/20 0.55
LMNA P02545 1/20 0.54
HTT P42858 1/20 0.51
MAPK1 P28482 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MIF P14174 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A3 Q01959 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1557396 0.86 TGM2 (0.54) TGM2CA12CA1CA2CA9
SCHEMBL8775648 0.84 ALDH1A1 (0.56) TGM2CA12CA1CA2CA9
SCHEMBL4493046 0.83 ALDH1A1 (0.57) TGM2CA12CA1CA2CA9
SCHEMBL4493048 0.83 ALDH1A1 (0.57) TGM2CA12CA1CA2CA9
SCHEMBL7448378 0.82 ALDH1A1 (0.55) TGM2CA12CA1CA2CA9
SCHEMBL14855359 0.82 ALDH1A1 (0.55) TGM2CA12CA1CA2CA9
SCHEMBL645150 0.82 ALDH1A1 (0.56) CA12CA1CA2CA9ALDH1A1
SCHEMBL3928127 0.82 LMNA (0.56) TGM2CA12CA1CA2CA9
SCHEMBL4291030 0.81 ALDH1A1 (0.54) CA12CA1CA2CA9ALDH1A1
SCHEMBL1415895 0.81 ALDH1A1 (0.55) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117164554-A FXR agonist and application thereof 中国医学科学院药物研究所 2023-12-05 CN claimed
CN-116396650-A Ink-absorbing coating 吉安天晟新材料有限公司 2023-07-07 CN claimed
CN-111171210-A Tetrafluoroethylene-alkenyl carbamate-perfluoroalkyl vinyl ether dispersion resin and microporous membrane prepared therefrom 苏州世华新材料科技股份有限公司 2020-05-19 CN claimed
EP-2952527-B1 ACRYLATE-STYRENE-ACRYLONITRILE POLYMER AND THERMOPLASTIC RESIN COMPOSITION LG CHEMICAL LTD (KR) 2017-05-24 EP claimed
US-9637622-B2 Acrylate-styrene-acrylonitrile polymer and thermoplastic resin composition LG CHEM, LTD. (KR) 2017-05-02 US claimed
US-20160152806-A1 ACRYLATE-STYRENE-ACRYLONITRILE POLYMER AND THERMOPLASTIC RESIN COMPOSITION LG CHEM, LTD. (KR) 2016-06-02 US claimed
EP-2952527-A1 ACRYLATE-STYRENE-ACRYLONITRILE POLYMER AND THERMOPLASTIC RESIN COMPOSITION LG Chem, Ltd. (KR) 2015-12-09 EP claimed
CN-105008421-A Acrylate-styrene-acrylonitrile polymer and thermoplastic resin composition LG CHEMICAL LTD 2015-10-28 CN claimed
EP-0444482-B1 Oxetanones HOFFMANN LA ROCHE (CH) 1996-01-17 EP claimed
US-5260310-A Oxetanone compounds and pharmaceutical compositions containing them HOFFMANN-LA ROCHE INC. (US) 1993-11-09 US claimed
CN-120289332-A N-vinyl benzyl carbamate and preparation method thereof 广安润康药业有限公司 2025-07-11 CN disclosed
US-12252490-B2 Inhibiting deubiquitinase USP25 and USP28 VALO HEALTH, INC. (US) 2025-03-18 US disclosed
WO-2025034745-A1 4-AMINOPIPERIDINES AS SELECTIVE MODULATORS OF POTASSIUM CHANNELS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2025-02-13 WO disclosed
CN-118307919-A Composite material of thermoplastic elastomer and polypropylene, and preparation method and application thereof 石家庄美速体育科技有限公司 2024-07-09 CN disclosed
CN-112823037-B Inhibition of deubiquitinase USP25 and USP28 瓦洛健康股份有限公司 2023-12-19 CN disclosed
WO-2000017164-A1 4-CARBOXYAMINO-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINES AS CETP INHIBITORS PFIZER PRODUCTS INC. (US) 2000-03-30 WO disclosed
WO-2000017165-A1 4-AMINO SUBSTITUTED-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINES AS CETP INHIBITORS PFIZER PRODUCTS INC. (US) 2000-03-30 WO disclosed
US-5466708-A Carbamyloxyoxetanone compounds HOFFMANN-LA ROCHE INC. (US) 1995-11-14 US disclosed
US-5376674-A Lipase inhibitors HOFFMAN-LA ROCHE INC. (US) 1994-12-27 US disclosed
US-5260310-A Oxetanone compounds and pharmaceutical compositions containing them HOFFMANN-LA ROCHE INC. (US) 1993-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12252490-B2 Inhibiting deubiquitinase USP25 and USP28 USP28, USP25, USP30 TGM2 1004/4885CA12 2995/4885CA1 3026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.